R&D Digital Lead

Location: London, UK
Job Type: Full-Time
Employer: GlaxoSmithKline
As the R&D Digital Lead, you will be responsible for partnering across all GSK Consumer Health categories to develop a strategic pipeline of digital healthcare innovation. This will include pioneering new, creative approaches to develop intuitive digital diagnostics and therapeutics, as well as evaluating digital devices/sensors/apps either marketed or in various stages of development. You will be a key contributor to the R&D innovation strategy to deliver digital innovation including: devices, wearables, software, and apps.

You will lead a team with responsibility for overall prototype design from concepts through large scale manufacturing with contract manufacturers. You will be a member of the Digital Innovation Hub (DIH) Leadership Team and serve on the Digital Innovation Board (DIB).

Key Responsibilities

  • You will be responsible for managing a portfolio of digital health opportunities to deliver at least one opportunity per year.
  • You will set the strategy and manage a team of ~10 direct & indirect cross-functional reports (Regulatory, Medical, Quality, Supply, Technical Leads, etc.) to provide expert support/project input to device innovation projects in close partnerships with the category project teams/management as well as establish new innovation platform areas.
  • As the successful incumbent, you will establish and maintain world-leading, cross-functional capabilities in a newly established Digital Innovation Hub and enable rapid prototyping (hardware/sensors, apps, etc.) capabilities for early stage Consumer Science evaluation.
  • You will create partner selection criteria for various partner categories. Manage internal and external partners to step-change GSK Consumer Healthcare ability to drive big-bet, digital breakthrough global innovation across all categories.
  • In this role, you will establish new research platforms into new technologies to enable digital diagnostics and treatment aids, including IP strategy.

Closing date for applications: May 15th 2018

Basic qualifications

  • BSc in Computer Science, Physics or Engineering ideally with a Business degree or equivalent
  • Significant and broad experience in device product development
  • Knowledge and deep understanding of the digital health (devices/apps/data) and broader trends in healthcare landscape.
  • Strong and broad understanding of deep scientific knowledge with ability to translate into new cross-category global platforms.
  • Excellent analytical and strategic thinking skills with strong expertise in managing multi-disciplinary, matrixed teams.
  • Excellent leadership and communication skills given large portfolio impact and multiple 1:1 interactions with senior internal / external stakeholders.
  • Line leader experience

Preferred qualifications

  • MA/MS/MBA in Computer Science, Engineering or Business
  • Advanced education in digital health (AI, devices, apps, etc.) and business.

Apply for this job

About GSK

GSK - a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer.

Post your job offer now to start hiring the best digital health talent! For further information, please contact us.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...